Live feed08:54:31·37dANALYSTRatingvia QuantisnowRodman & Renshaw initiated coverage on Sagimet Biosciences with a new price targetByQuantisnow·Wall Street's wire, on your screen.SGMT· Sagimet Biosciences Inc.Health CareOriginal source